Manon Bosseler
Luxembourg, LU L1210, Luxembourg
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The BET Protein Inhibitor JQ1 Decreases Hypoxia and Improves the Therapeutic Benefit of Anti-PD-1 in a High-Risk Neuroblastoma Mouse Model.
Journal: Cells
Published: July 14, 2022
The β-carboline Harmine improves the therapeutic benefit of anti-PD1 in melanoma by increasing the MHC-I-dependent antigen presentation.
Journal: Frontiers in immunology
Published: June 28, 2022
Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy.
Journal: Oncogene
Published: August 31, 2020
Driving Cytotoxic Natural Killer Cells into Melanoma: If CCL5 Plays the Music, Autophagy Calls the Shots.
Journal: Critical reviews in oncogenesis
Published: October 13, 2018
Inhibition of HIF1α-Dependent Upregulation of Phospho-l-Plastin Resensitizes Multiple Myeloma Cells to Frontline Therapy.
Journal: International journal of molecular sciences
Published: April 05, 2018
Epigenetic Activity of Peroxisome Proliferator-Activated Receptor Gamma Agonists Increases the Anticancer Effect of Histone Deacetylase Inhibitors on Multiple Myeloma Cells.
Journal: PloS one
Published: January 22, 2015
Bronchial airway gene expression in smokers with lung or head and neck cancer.
Journal: Cancer medicine
Published: June 28, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026